GGrantIndex
Sort

53,477 grants matching addiction

NDA-Enabling Phase I Lofexidine Program

$1,107,186
James Alvan Longstreth · Us Worldmeds, Llc · U01 · FY2013 · DA

Rational design and targeted selection of DNA-scaffolded nicotine vaccines

$1,106,887
Yung Chang · Arizona State University-Tempe Campus · R01 · FY2013 · DA

Improving Physician Opioid Prescribing for Chronic Pain in HIV-infected Persons

$1,106,535
Jeffrey H Samet · Boston Medical Center · R01 · FY2015 · DA

ADDICTIONS: GENOTYPES, POLYMOPHISMS, AND FUNCTION

$1,106,441
Rockefeller University · R01 · FY2002 · DA

Clinical Trials Network: Pacific Northwest Node

$1,106,411
Dennis M Donovan · University Of Washington · U10 · FY2014 · DA

Florida Node Alliance of the Drug Abuse Clinic Trials Network

$1,106,274
Jose Szapocznik · University Of Miami School Of Medicine · U10 · FY2012 · DA

Developing Radiocaine NaV imaging as a response monitoring biomarker for chronic pain

$1,106,020
Braxton Norwood · Lutroo Imaging Llc · UG3 · FY2023 · NS

Single Cell Transcriptomics of the Opioid Use Disorder and HIV Syndemic in the Human Brain

$1,105,894
Christine Cheng · J. Craig Venter Institute, Inc. · UM1 · FY2021 · DA

Improving Physician Opioid Prescribing for Chronic Pain in HIV-infected Persons

$1,105,595
Jeffrey H Samet · Boston Medical Center · R01 · FY2014 · DA

Maternal Opioid Treatment: Human Experimental Research

$1,105,489
Hendree E. Jones · Johns Hopkins University · R01 · FY2008 · DA

The Use of Novel Linked Databasesto Reduce Postoperative Opioid Use Among Patients Undergoing Inpatient Surgery

$1,105,489
Eric Sun · Stanford University · R61 · FY2023 · DA

Clinical Trials Network: Southwest Node

$1,105,058
Michael Parks Bogenschutz · University Of New Mexico · U10 · FY2012 · DA

CENTER ON INTERSYSTEM REGULATION BY DRUGS OF ABUSE

$1,105,042
Temple University · P30 · FY2001 · DA

Neuron-Specific Candidate Gene Expression and Adolescent Vulnerability to Smoking

$1,104,333
Burt M Sharp · University Of Tennessee Health Sci Ctr · RC2 · FY2010 · DA

HD2A RASC-Research and Evaluation Core

$1,104,230
C. Hendricks Brown · Stanford University · U2C · FY2022 · DA

DSC MANAGEMENT AND SUPPORT FOR HELPING TO END ADDICTION LONG-TERM INITIATIVE (HEAL). 9/21/2020-9/20/2021. N01DA-19-2250. TASK ORDER 75N95020F00008 (TO

$1,104,229
Paul Vanveldhuisen · The Emmes Company, Llc · N01 · FY2020 · DA

Structure and Function of Neurotransmitter Transporters

$1,104,130
Harel Weinstein · Weill Medical Coll Of Cornell Univ · P01 · FY2015 · DA

Prevention of Relapse in Addiction

$1,103,426
Kenzie Preston · National Institute On Drug Abuse · ZIA · FY2010 · DA

Appalachian Node

$1,103,283
Jane M Liebschutz · University Of Pittsburgh At Pittsburgh · UG1 · FY2021 · DA

Endocannabinoid Active Sites as Therapeutic Targets

$1,102,420
Alexandros Makriyannis · Northeastern University · P01 · FY2008 · DA

ORWH: SCOR on Sex and Gender Factors Affecting Women's Health

$1,101,910
Kathleen Theresa Brady · Medical University Of South Carolina · P50 · FY2012 · DA

Appalachian Tri-State Node

$1,101,887
Antoine B Douaihy · University Of Pittsburgh At Pittsburgh · U10 · FY2014 · DA

Orbitrap Tribrid Mass Spectrometer

$1,101,448
Larry L David · Oregon Health & Science University · S10 · FY2021 · OD

Synaptic Transmission: Modulation, Plasticity And Effects Of Drugs Of Abuse

$1,101,304
David M Lovinger · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2015 · AA

Dynamic Signal Processing Analyses of Neural Plasticity

$1,101,233
Emery Neal Brown · Massachusetts General Hospital · R01 · FY2006 · DA